Latest filing published 20 Aug 2026 for Hims & Hers Health, Inc., €403k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Deborah M. Autor, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Hims & Hers Health, Inc. and Amneal Pharmaceuticals, Inc. In total, 16 filings cover trades dated from 30 July 2023 to 18 August 2026.
Sales make up the whole of the open-market record (5 sales, €1.2M). Besides market trades, the filings include 2 share grants and 9 option exercises. Since January 2026: no purchases and 2 sales on the market.
The latest filing, published on 20 August 2026, reports an open-market sale of €403k in Hims & Hers Health, Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations